Scientists reveal new lines of attack to raise cancer survival rate | Cancer research | The Guardian
The ICR on Twitter: "Professor Kevin Harrington specialises in #HeadAndNeckCancer. He and his team study the use of biologically targeted agents, in combination with treatments such as #Radiotherapy and #Chemotherapy, to target #
Professor Kevin Harrington - The Institute of Cancer Research, London
High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London
ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers - The Institute of Cancer Research, London
ICR calls for improved biomarker cancer tests to help personalise treatment - PMLiVE
The ICR on Twitter: "Today, Prof. Kevin Harrington (ICR/@cancerBRC) will present on a trial of RP2, a first-in-class, enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody as a single agent and combined
.jpg?sfvrsn=a729a68_4 "Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses - The Institute of Cancer Research, London")
Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
The ICR on Twitter: "We were delighted to welcome @JonAshworth (MP & Shadow Health Secretary) to visit us today with @CRUK_Policy to meet Professor Kevin Harrington and team. Jon saw some of
Cancer survival 'to double in 10 years' - PressReader
The ICR on Twitter: "Watch Professor Kevin Harrington on @BBCLondonNews as he shares more on how a modified version of the herpes virus could offer hope for some people with advanced #Cancer.
The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR + @royalmarsdenNHS) featured earlier in a @BBCr4today segment on #immunotherapy. In the UK you can still listen to today's live program
The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter
Get A-Head Visit The Institute of Cancer Research - Get Ahead
Professor Kevin Harrington - The Institute of Cancer Research, London
Oracle funded research being reviewed for major international Cancer Research journal - Oracle Cancer Trust
Connections blog - ICR celebrates innovation and commercialisation at staff awards - The Institute of Cancer Research, London
Cancer: Scientists aim to double survival within a decade | The Independent
-(1).jpg?sfvrsn=afff2c69_2 "Science Talk - Immunotherapy goes viral: ICR research on cancer-killing viruses featured on BBC's The One Show - The Institute of Cancer Research, London")
Science Talk - Immunotherapy goes viral: ICR research on cancer-killing viruses featured on BBC's The One Show - The Institute of Cancer Research, London
Kevin Harrington - Reader in Biological Cancer Therapies - Institute of Cancer Research | LinkedIn
Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - YouTube
Professor Kevin... - The Institute of Cancer Research | Facebook
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
